Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 3
2016 3
2017 2
2018 6
2019 2
2020 4
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Bariatric procedures and microbiota: patient selection and outcome prediction.
Puca P, Petito V, Laterza L, Lopetuso LR, Neri M, Del Chierico F, Boskoski I, Gasbarrini A, Scaldaferri F. Puca P, et al. Among authors: laterza l. Ther Adv Gastrointest Endosc. 2021 Jul 20;14:26317745211014746. doi: 10.1177/26317745211014746. eCollection 2021 Jan-Dec. Ther Adv Gastrointest Endosc. 2021. PMID: 34368762 Free PMC article. Review.
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.
Laterza L, Ianiro G, Scoleri I, Landi R, Bruno G, Scaldaferri F, Gaetani E, Campanale M, Gasbarrini A. Laterza L, et al. Expert Opin Pharmacother. 2015 Mar;16(4):607-15. doi: 10.1517/14656566.2015.1007951. Epub 2015 Feb 1. Expert Opin Pharmacother. 2015. PMID: 25641072 Review.
Role of yeasts in healthy and impaired gut microbiota: the gut mycome.
Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Ianiro G, et al. Among authors: laterza l. Curr Pharm Des. 2014;20(28):4565-9. doi: 10.2174/13816128113196660723. Curr Pharm Des. 2014. PMID: 24180411 Review.
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Scaldaferri F, et al. Among authors: laterza l. Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7. Biomed Res Int. 2013. PMID: 23991417 Free PMC article. Review.
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.
Pugliese D, Privitera G, Rogai F, Variola A, Viola A, Laterza L, Privitera AC, Allocca M, Bossa F, Cappello M, Daperno M, Lorenzon G, Mazzuoli S, Principi M, Sablich R, Moser L, Ferronato A, Traini S, Tapete G, Bodini G, Di Girolamo M, Grossi L, Mocci G, Ricci C, Saibeni S, Festa S, Spagnuolo R, Cortelezzi CC, Mocciaro F, Rizzello F, Armuzzi A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Pugliese D, et al. Among authors: laterza l. United European Gastroenterol J. 2021 Feb;9(1):102-109. doi: 10.1177/2050640620974308. Epub 2021 Mar 1. United European Gastroenterol J. 2021. PMID: 33203342 Free PMC article.
29 results